OPACE - COPD Trial
OPACE is a clinical trial funded by NIHR in collaboration with Addenbrookes hospital.
The OPACE trial aims to find out how best to use azithromycin in chronic obstructive pulmonary disease (COPD).
OPC UK is collaborating with Cambridge University NHS Foundation Trust to help with the recruitment of practices (as Patient Identification Centres – PICs) for the trial.
All PIC practices will receive full support from OPC to identify, invite and refer patients to the trial. No further practice involvement is required as all study visits are performed remotely and by a trial centralized team, NO practice or study site visits are required.
PIC (Practice Identification Centre Model)
Table Design
PIC Practice Role – Managed by OPC
Patient Involvement
-
Study invitation from Practice
-
Phone call from HCP and remote COPD review
-
Enrolled and randomized to medication (azithromycin or placebo for 20 months)
-
Monitored and followed up by phone or video (up to 6 times)
-
Patient reported outcomes, so no major tests or hospital visits
Benefits for Patients
Patients can take part entirely from home
-
Free trial medication is delivered to patients’ homes
-
More healthcare professional follow -ups from hospital team
-
Amazon Gift Voucher
To join OPACE, please contact us at OPACE@optimumpatientcare.org Tel: 01223 96785